The therapeutic potential of mitochondrial toxins

Area of Science:

• Biochemistry
• Pharmacology
• Oncology

Background:

• Mitochondrial toxins can affect cellular functions and exhibit varying toxicity.
• Inhibitors of oxidative phosphorylation (OXPHOS) complexes are often avoided in drug discovery due to potential toxicity.
• Targeting mitochondrial functions, especially OXPHOS, is an emerging anti-cancer strategy.

Purpose of the Study:

• To review the therapeutic potential of OXPHOS inhibitors as anti-cancer drug candidates.
• To examine the significance of mitochondrial toxins in cancer treatment.
• To discuss microbial-derived compounds with OXPHOS inhibitory activity.

Main Methods:

• Literature review of scientific articles and drug discovery data.
• Analysis of the role of mitochondrial toxins in cellular processes.
• Examination of anti-cancer strategies targeting OXPHOS.

Main Results:

• Mitochondrial toxins, including OXPHOS inhibitors, can possess beneficial anti-cancer effects.
• Compounds of microbial origin are a notable source of potential OXPHOS-inhibiting anti-cancer drugs.
• Targeting OXPHOS offers a promising avenue for novel cancer therapies.

Conclusions:

• OXPHOS inhibitors represent a viable class of anti-cancer drug candidates.
• Further research into microbial-derived OXPHOS inhibitors could lead to new cancer treatments.
• Targeting mitochondrial respiration presents a significant opportunity in oncology.